Now showing items 1-3 of 3
RESPIRATORY IMPAIRMENT IN TUBERCULOSIS AND HIV (RESPITH): TRENDS, PREDICTORS AND IMPLICATIONS
(Johns Hopkins University, 2017-12-07)
Tuberculosis (TB) and human immunodeficiency virus (HIV) have been associated with chronic lung injury and obstructive lung disease (OLD). Despite the enormous global burden of TB and HIV, their epidemiological overlap in ...
Evaluating the Impact of Strategies for Tuberculosis Prevention and Control in High-Burden, Low-Resource Settings: Data for Evidence-Based Decision-Making in Local Contexts
(Johns Hopkins University, 2015-10-29)
Background: While incidence rates of tuberculosis (TB) are on the decline globally, the TB burden in sub-Saharan Africa and Southeast Asia remains high. If the goal of reducing the global TB incidence rate to < 10/100,000 ...
PROVIDER BARRIERS, ENABLERS, AND INCENTIVES ASSOCIATED WITH THE USE OF ISONIAZID PREVENTIVE THERAPY AMONG HIV-INFECTED INDIVIDUALS IN ETHIOPIA
(Johns Hopkins University, 2017-06-30)
Background: Isoniazid preventive therapy (IPT) is given to patients with latent infection of tuberculosis (TB) to prevent the progression to active disease. The World Health Organization (WHO) recommends six to nine months ...